CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 209.9	$ 267.1
Short-term investments	210.6	201.2
Accounts receivable, net	233.4	234.7
Inventories	460.1	422.0
Other current assets	111.4	106.5
Total current assets	1,225.4	1,231.5
Property, plant and equipment, net	239.0	231.1
Intangibles, net and other long-term assets	275.4	267.4
Total assets	1,739.8	1,730.0
Current liabilities:
Current portion of long-term debt	20.4	0.6
Accounts payable	95.1	72.1
Customer advances	146.4	178.3
Other current liabilities	279.8	303.5
Total current liabilities	541.7	554.5
Long-term debt	281.8	265.2
Other long-term liabilities	$ 207.2	$ 177.4
Commitments and contingencies (Note 10)
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding
Common stock, $0.01 par value 260,000,000 shares authorized, 170,223,598 and 169,644,644 shares issued and 162,554,756 and 165,354,180 shares outstanding at March 31, 2016 and December 31, 2015, respectively	$ 1.7	$ 1.7
Treasury stock, at cost, 7,668,905 and 4,290,527 shares at March 31, 2016 and December 31, 2015, respectively	(174.1)	(90.9)
Accumulated other comprehensive loss	(11.8)	(44.2)
Other shareholders' equity	886.3	859.5
Total shareholders' equity attributable to Bruker Corporation	702.1	726.1
Noncontrolling interest in consolidated subsidiaries	7.0	6.8
Total shareholders' equity	709.1	732.9
Total liabilities and shareholders' equity	$ 1,739.8	$ 1,730.0